Article

POSTER: CML-449 JAK2-Unmutated Erythrocytosis in Chronic Phase Myeloid Leukemia (CP-CML) During Tyrosine Kinase Inhibitor (TKI) Treatment

Olga KuleminaAlmazov National Medical Research Centre, St. Petersburg, Russian FederationJulia YakovlevaRaisa Gorbacheva Memorial Institute for Children Hematology and Transplantology, St. Petersburg, Russian FederationNatalia LazorkoAlmazov National Medical Research Centre, St. Petersburg, Russian FederationTamara ChitanavaAlmazov National Medical Research Centre, St. Petersburg, Russian FederationNadia SiordiaAlmazov National Medical Research Centre, St. Petersburg, Russian FederationNadezhda ShnalievaAlmazov National Medical Research Centre, St. Petersburg, Russian FederationElena TochenayaAlmazov National Medical Research Centre, St. Petersburg, Russian FederationPolina MateikovichAlmazov National Medical Research Centre, St. Petersburg, Russian FederationElza LomaiaAlmazov National Medical Research Centre, St. Petersburg, Russian Federation

Clinical Lymphoma Myeloma & Leukemiajournal2023en

ABI

Abstract

No abstract available.

Topics

Chronic Myeloid Leukemia Treatments Myeloproliferative Neoplasms: Diagnosis and Treatment Chronic Lymphocytic Leukemia Research

Identifiers

DOI: 10.1016/s2152-2650(23)00571-2

Citations and references

Cited by 00 references

Metrics — AkademScholar · Coming soon